Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.

被引：0
|
作者：
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Khanh Tu Do
Holbeck, Susan
Hollingshead, Melinda G.
Horneffer, Yvonne
Juwara, Lamin
Srivastava, Apurva K.
Rubinstein, Larry
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Antony, Ramya
Collins, Jerry M.
Chen, Alice
Doroshow, James H.
机构：
[1] Early Clin Trials Dev Program, Bethesda, MD USA
[2] Stanford Univ, Sch Med, Phase Clin Res Program 1, Stanford, CA 94305 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
[5] NCI, Div Canc Treatment & Diag, NIH, Frederick, MD 21701 USA
[6] NCI, Bethesda, MD 20892 USA
[7] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
[8] Div Canc Treatment & Diag, Bethesda, MD USA
[9] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA
[10] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[11] NCI, Rockville, MD USA
[12] Leidos Biomed Res Inc, Frederick, MD USA
[13] NCI, DCTD, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2614
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study of danusertib (D) in combination with bevacizumab (B) in solid tumors.
    Rosen, P. J.
    Tolcher, A. W.
    Lee, P.
    Smitley, M.
    Fuerst, M.
    Spinelli, R.
    Crippa, S.
    Jannuzzo, M. G.
    Comis, S.
    Papadopoulos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [43] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] A phase I study of ARQ 197 in combination with temsirolimus in advanced solid tumors.
    Kyriakopoulos, Christos
    Kolesar, Jill
    Eickhoff, Jens C.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari Braun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] A phase II study of pazopanib in children, adolescents, and young adults with refractory solid tumors.
    Lee, Alice
    Bender, Julia Glade
    Weigel, Brenda
    Fox, Elizabeth
    Huff, Anne C.
    Tada, Hiroomi
    Blaney, Susan M.
    Langmuir, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
    Berkenblit, Anna
    Eder, Joseph P., Jr.
    Ryan, David P.
    Seiden, Michael V.
    Tatsuta, Noriaki
    Sherman, Matthew L.
    Dahl, Thomas A.
    Dezube, Bruce J.
    Supko, Jeffrey G.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 584 - 590
  • [47] A phase I clinical trial of vorinostat in combination with sFULV2 in patients with refractory solid tumors
    Fakih, M. G.
    Pendyala, L.
    Egorin, M. J.
    Fetterly, G.
    Espinoza-Delgado, I.
    Ross, M.
    Phelan, J.
    Kramer, Z.
    Yirinec, B.
    Diasio, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase I evaluation of troxacitabine administered by continuous infusion in patients with refractory solid tumors.
    Hidalgo, M
    Lee, C
    Carducci, K
    Jolivet, J
    Baker, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 144S - 144S
  • [49] A phase I study of gefitinib and irinotecan (IRN) in pediatric patients with refractory solid tumors.
    Furman, WL
    Daw, NC
    Crews, KR
    Stewart, CF
    McCarville, B
    Santana, VM
    Hawkins, D
    Rodriguez-Galindo, C
    Navid, F
    Houghton, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 804S - 804S
  • [50] a Phase I Trial of Bendamustine in Combination with Clofarabine and Etoposide in Pediatric Patients with Relapsed or Refractory Hematologic Malignancies
    Jeha, Sima
    Metzger, Monika L.
    Crews, Kristine R.
    Campbell, Patrick
    Ribeiro, Raul C.
    Cheng, Cheng
    Peyton, Melissa
    Panetta, Carl
    Yang, Jun
    Pui, Ching-Hon
    Bhojwani, Deepa
    BLOOD, 2016, 128 (22)
12345